Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
GPHBF Graphene 3D Lab Inc(British Columbia)
ITRI Itron Inc
LTTTX MFS Lifetime 2025 Fund Class R3
HLI Houlihan Lokey Inc
KICK Master Glazier's Karate International Inc
VIRT Virtu Financial Inc
FB Facebook Inc
ED Consolidated Edison Inc
CLS Celestica Inc
Go

Financials : Banks | Large Cap Value
Company profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.

Closing Price
$33.01
Day's Change
-0.98 (-2.88%)
Bid
--
Ask
--
B/A Size
--
Day's High
33.63
Day's Low
32.70
Volume
(Average)
Volume:
57,684,295

10-day average volume:
54,207,175
57,684,295

BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. - BIIB

10:16 am ET November 19, 2020 (Globe Newswire) Print

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Biogen Inc. (NASDAQ: BIIB) between October 22, 2019 and November 6, 2020, inclusive (the "Class Period").

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=biogen-inc&id=2484 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

å¦?æ??æ?¨æ?³å? å?¥è¿?个é??ä½"è¯?讼æ¡?ï¼?请å?¨è¿?é??提交æ?¨ç??信息ã??http://zhanginvestorlaw.com/join-action-form/?slug=biogen-inc&id=2484.

If you wish to serve as lead plaintiff, you must move the Court before the January 12, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: the larger dataset did not provide necessary data regarding aducanumab's effectiveness; the EMERGE study did not and would not provide necessary data regarding aducanumab's effectiveness; the PRIME study did not and would not provide necessary data regarding aducanumab's effectiveness; the data provided by the Company to the FDA's Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.

99 Wall Street, Suite 232

New York, New York 10005

info@zhanginvestorlaw.com

tel: (800) 991-3756

https://ml.globenewswire.com/media/2e68a1c2-58ac-4be0-98d5-8b26afb52403/small/zahng-investor-law-png.png

https://ml.globenewswire.com/media/2e68a1c2-58ac-4be0-98d5-8b26afb52403/small/zahng-investor-law-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.